This article provides a detailed comparison of two premier cytosine base editors, BE4max and Sdd7, tailored for researchers and drug developers.
This comprehensive review details the pivotal role of the BCL11A transcription factor in silencing fetal hemoglobin (HbF) and its emergence as a prime therapeutic target for sickle cell disease (SCD).
This comprehensive guide details the protocol for editing the BCL11A enhancer region to produce exagamglogene autotemcel (exa-cel), an autologous CRISPR-Cas9 edited cell therapy for sickle cell disease and beta-thalassemia.
This article provides a complete framework for implementing amplicon sequencing to assess candidate off-target sites for CRISPR-based therapies.
This article provides a detailed, up-to-date protocol and analysis of the Alt-R HDR Enhancer Protein, a key reagent for enhancing Homology-Directed Repair (HDR) in CRISPR-Cas9 genome editing.
This article explores AiCErec, a cutting-edge AI-assisted platform for recombinase engineering, tailored for researchers and drug development professionals.
This comprehensive guide details the optimized protocol for Agrobacterium-mediated transformation of embryogenic cell suspensions (ECS), a cornerstone technique for advanced plant genetic engineering and molecular pharming.
This article provides a detailed guide for researchers and biotechnologists on utilizing Agrobacterium tumefaciens as a vector for CRISPR-Cas9 genome editing.
This comprehensive analysis explores the critical choice between Agrobacterium-mediated transformation and biolistic delivery for CRISPR-Cas genome editing.
This article provides a detailed guide for researchers and biotechnologists on selecting and optimizing Agrobacterium strains for efficient CRISPR-Cas delivery in plants.